Annals of Internal Medicine, Ahead of Print.
Risultati per: Terapia antibiotica: breve durata vs. lunga durata
Questo è quello che abbiamo trovato per te
After PSA screening, MRI-targeted vs. systematic biopsy detected fewer clinically insignificant prostate cancers
Annals of Internal Medicine, Ahead of Print.
In BPPV, canalith repositioning maneuver increased symptom resolution vs. vestibular suppressants
Annals of Internal Medicine, Ahead of Print.
In pituitary adenoma surgery, no vs. perioperative hydrocortisone was noninferior for new-onset adrenal insufficiency
Annals of Internal Medicine, Ahead of Print.
In older adults with hypertension, chlorthalidone vs. hydrochlorothiazide did not reduce major CV events or deaths at 2.4 y
Annals of Internal Medicine, Ahead of Print.
Medicare Advantage vs Traditional Medicare and 30-Day Mortality in Patients With AMI—Reply
In Reply As noted by Dr Roehm, Medicare Advantage health plans principally are paid via capitation payments that are adjusted for the health status of the enrolled population. A large body of research suggests that this payment system has created strong incentives for Medicare Advantage health plans to improve their coding of diagnoses in order to increase their payments. The Medicare Payment Advisory Commission (MedPAC) estimated that Medicare Advantage risk scores in 2021 were more than 10% higher than scores for similar beneficiaries in traditional Medicare . To achieve these scores, Medicare Advantage plans rely on more intensive coding of diagnoses by their clinicians as well as chart audits and home visits to obtain additional diagnosis codes.
Medicare Advantage vs Traditional Medicare and 30-Day Mortality in Patients With AMI
To the Editor A recent study compared outcomes of 30-day mortality following myocardial infarction in patients with Medicare Advantage vs traditional Medicare. However, greater coding intensity occurs in Medicare Advantage plans, which makes reliable interpretation of outcome data difficult when comparing Medicare Advantage plans with traditional Medicare.
Birth Outcomes Following ART Conception in Same-Sex Lesbian Couples vs Natural and ART Conception in Heterosexual Couples
This study uses registry data to compare birth outcomes, including birth weight, gestational age, low birth weight, and preterm delivery, in assisted reproductive technology (ART) pregnancies among same-sex lesbian couples vs natural conceptions and ART pregnancies among heterosexual couples.
Allogeneic HCT vs Consolidation Chemotherapy in Patients With Intermediate-Risk Acute Myeloid Leukemia
This randomized clinical trial of adults with intermediate-risk acute myeloid leukemia explores the optimal therapy for these patients after complete remission.
Immune-Related Gene Expression Signatures vs Tumor-Infiltrating Lymphocytes in ERBB2/HER2-Positive Breast Cancer
This prognostic study (in which a combined correlative analysis of the CALGB 40601 and PAMELA trials was conducted) compares the effectiveness of tumor-infiltrating lymphocytes vs immune-related gene expression signatures in predicting pathologic complete response and event-free survival in patients with early-stage ERBB2/HER2-positive breast cancer.
Specialized Early Intervention Services vs Treatment as Usual For First-Episode Schizophrenia Spectrum Disorder
This 20-year follow-up of a randomized clinical trial reports the long-term associations of early intervention services compared with treatment as usual for individuals with first-episode schizophrenia spectrum disorder.
Effects of Opt-out vs Opt-in Tobacco Treatment
This randomized clinical trial evaluates the efficacy of opt-out care vs opt-in care for people who use tobacco.
Comparative Effectiveness of Anti-TNF in Combination with Low Dose Methotrexate vs Anti-TNF Monotherapy in Pediatric Crohn’s Disease: a Pragmatic Randomized Trial
Tumor Necrosis Factor inhibitors (TNFi), including infliximab and adalimumab, are a mainstay of pediatric Crohn’s disease (PCD) therapy; however, non-response and loss of response is common. As combination therapy with methotrexate may improve response, we performed a multi-center, randomized, double-blind, placebo-controlled pragmatic trial to compare TNFi with oral methotrexate to TNFi monotherapy.
Singapore, una nuova terapia contro il cancro
Ricorrendo a globuli bianchi di donatori sani
Higher-Dose Ivermectin vs Placebo and Time to Sustained Recovery in Outpatients With COVID-19
This platform randomized clinical trial examines the effectiveness of ivermectin at a targeted dose of 600 μg/kg daily compared with placebo for the treatment of early mild to moderate COVID-19.
Early vs Interval Postpartum Intrauterine Device Placement
This randomized clinical trial examines the expulsion rate of intrauterine devices placed between 2 to 4 weeks postpartum compared with standard placement timing at 6 to 8 weeks postpartum.